CCI
49
3
FLR
40
4
NEM
55
2
BK
68
2
NI
70
-2
IRM
42
-4
CTAS
46
-3
CCL
53
-4
A
47
3
NFLX
68
-2
KIM
58
4
MTB
55
-4
CLX
62
-6
GME
52
-2
CMG
43
-4
APD
42
-3
KMB
45
-2
AA
51
-3
CNX
59
4
IBM
55
-2
CCI
49
3
FLR
40
4
NEM
55
2
BK
68
2
NI
70
-2
IRM
42
-4
CTAS
46
-3
CCL
53
-4
A
47
3
NFLX
68
-2
KIM
58
4
MTB
55
-4
CLX
62
-6
GME
52
-2
CMG
43
-4
APD
42
-3
KMB
45
-2
AA
51
-3
CNX
59
4
IBM
55
-2
Financhill
Back

Ultra Clean Holdings Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
34

UCTT
Ultra Clean Holdings

Last Price:
$24.86
Seasonality Move:
8.12%
Sell
48

ASND
Ascendis Pharma AS

Last Price:
$164.87
Seasonality Move:
-9.72%
Sell
34
Ultra Clean Holdings (UCTT) is a Sell

Is Ultra Clean Holdings a Buy, Sell or Hold?

  • The current Ultra Clean Holdings [UCTT] share price is $24.91. The Score for UCTT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • UCTT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $164.65. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UCTT Stock Price Chart

What is Ultra Clean Holdings's stock price today?

  • The Ultra Clean Holdings share price today is $24.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $164.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

UCTT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 36.49 Sell
Chaikin Money Flow: -297878 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.43 - 36.55) Sell
Bollinger Bands (100): (30.47 - 39.65) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.96 Buy
Relative Strength Index (14 RSI): 63.68 Buy
Chaikin Money Flow: -280747 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.08 - 160.62) Buy
Bollinger Bands (100): (124.26 - 145.68) Buy

UCTT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.6 Buy
20-day SMA: 28.05 Sell
50-day SMA: 33.57 Sell
200-day SMA: 38.64 Sell
8-day EMA: 25.06 Sell
20-day EMA: 27.55 Sell
50-day EMA: 31.63 Sell
200-day EMA: 36.36 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 154.01 Buy
20-day SMA: 153.39 Buy
50-day SMA: 139.38 Buy
200-day SMA: 134.63 Buy
8-day EMA: 157.06 Buy
20-day EMA: 151.09 Buy
50-day EMA: 143.18 Buy
200-day EMA: 134.95 Buy

Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.24 per share, an increase this year of $0.52 per share, and an increase next year of $1.09 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.

Ultra Clean Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):